You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
16 April 2024 - Pharmaceutical company Amneal Pharmaceuticals Inc (Nasdaq: AMRX) announced on Tuesday that it has introduced PEMRYDI RTU, the inaugural ready-to-use version of pemetrexed for injection, offering convenience by eliminating reconstituti...
16 April 2024 - Biotherapeutics company PureTech Health plc (Nasdaq: PRTC) (LSE: PRTC) announced on Tuesday that it has completed patient enrollment in the ELEVATE IPF Phase 2b trial for LYT-100, a deuterated form of pirfenidone, targeting idiopathic...
16 April 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) announced on Tuesday that the US FDA has accepted its 5-in-1 meningococcal ABCWY vaccine candidate for regulatory review. The Prescription Drug User Fee Act (PDUFA) action date is set ...
16 April 2024 - Medivir AB (Nasdaq: MVIR) (Stockholm: MVIR), a Sweden-based pharmaceutical company engaged in developing innovative treatments for cancer in areas of high unmet medical need, announced on Monday that its partner Vetbiolix, a veterinar...
16 April 2024 - Norgine BV, a Netherlands-based specialist pharmaceutical company, announced on Monday that it has submitted its first marketing authorisation application submissions on 10 April 2024 for the approval of eflornithine in high-risk neur...
16 April 2024 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company, announced on Monday that it has named Dr Nageatte Ibrahim as its new oncology CMO.In the new role, Dr Ibrahim is to provide the strategy, execution and l...
15 April 2024 - Biotechnology company UroGen Pharma Ltd (Nasdaq: URGN) announced on Monday that the FDA has accepted the Investigational New Drug (IND) application for UGN-103, a novel mitomycin-based formulation targeting low-grade intermediate-risk...